11 – 20 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Immunological Aspects of Soft Tissue Sarcoma and Melanoma. Correlation to prognosis and treatment
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Pain and function in patients with chronic low back pain and leg pain after Zhineng Qigong : a quasi-experimental feasibility study
(
- Contribution to journal › Article
- 2022
-
Mark
Prolonged exposure for pain and comorbid PTSD: A single-case experimental study of a treatment supplement to multiprofessional pain rehabilitation
(
- Contribution to journal › Article
-
Mark
Physical Activity at Growth Induce Bone Mass Benefits Into Adulthood : A 15-Year Prospective Controlled Study
(
- Contribution to journal › Article
-
Mark
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort
(
- Contribution to journal › Article
-
Mark
Early Brain Volume Changes After Stroke : Subgroup Analysis From the AXIS-2 Trial
(
- Contribution to journal › Article
-
Mark
Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness
(
- Contribution to journal › Article
- 2021
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
(
- Contribution to journal › Article
-
Mark
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months
(
- Contribution to journal › Article